Abstracts Published from the 17th Annual Cardiometabolic Health Congress
Abstracts presented on topics in cardiorenal and cardiometabolic health at the 17th Annual Cardiometabolic Health Congress (CMHC) conference in Boston have been published in Postgraduate Medicine. The fifth annual Scientific Poster Sessions, hosted within the 17th Annual Cardiometabolic Health Congress (CMHC) at the Boston Park Plaza in Oct. 2022, allowed investigators from around the world to […]
Worse cardiometabolic health, more social determinants increase odds for severe COVID-19
Adults with a higher cardiometabolic disease staging score who also experience social determinants of health have increased risks for severe COVID-19 outcomes, according to study findings published in Obesity. In a retrospective analysis of patient electronic medical record data, researchers found prediction models that factored in cardiometabolic health history from the 3 years before COVID-19 […]
The Gut Microbiome and Cardiometabolic Health
Studies have linked inflammatory responses in the gut to a higher risk of developing cardiometabolic conditions such as cardiovascular disease (CVD) and type 2 diabetes (T2D). New research aims to test the hypothesis that diet modification can improve gut microbial composition and biosynthetic processes, which will, in turn, reduce inflammation and other biomarkers that are […]
Postgraduate Medicine’s Top 5 Cited Cardiometabolic Health Articles
By Howard A. Miller, MD As the Editor-in-Chief of Postgraduate Medicine (2020 Impact Factor: 3.84 and CiteScore: 4.4) I wanted to highlight the journal’s top 5 most cited articles in the cardiometabolic health field from the last 4 years. These articles explore various aspects of cardiometabolic health, including the definition of the interactions of risk […]
Hispanic Heritage Month: The State of Hispanic Cardiometabolic Health
An annual celebration of the vast historic and cultural achievements of Hispanic/Latino Americans, Hispanic Heritage Month begins each year on September 15th and ends on October 15th. During this time organizations in the medical industry aim to highlight the health concerns disproportionately affecting this demographic— which makes up nearly 20% of the overall U.S. population —while […]
National Public Health Week: The Cardiometabolic Clinician’s Role in Public Health
Taking place between April 5-11, 2021, National Public Health Week celebrates the importance of public health. This year, the week presents an opportunity to take a closer look at the particular challenges presented in the past year across the globe through a public health lens. In honor of this initiative, CMHC highlights the role of […]
The Cardiometabolic Medicine Market: Future Outlook and Industry Trends 2021
Delaying elective surgeries and routine health services, the COVID-19 pandemic is likely to have significant effects on medicine across a broad range of specialties, however, cardiometabolic medicine may experience these implications more acutely. As many risk factors – including heightened stress levels, increased sedentary lifestyles, and decreased physical activity – are currently being perpetuated by […]
5 Can’t Miss Topics at the 14th Annual CMHC
Top 5 Cardiometabolic Health Topics You Can’t Miss at the 14th Annual CMHC Alarmingly, recent statistics indicate that over one-third of the population has at least one cardiometabolic risk factor, ranging from dyslipidemia and hypertension to diabetes and cardiovascular disease. In the time of a cardiometabolic public health crisis, it is more important than ever […]
The Obesity Paradox in Patients with Type 1 Diabetes
In the past decade, the “obesity paradox” theory – which suggests an inverse association between BMI and cardiovascular outcome risk – has been a highly contested subject within the medical community. Type 1 diabetes is a well-established risk factor for cardiovascular disease, heart failure, and mortality, but it may prove especially detrimental in overweight and obese […]
